LWEL — Luckwel Pharmaceuticals Cashflow Statement
0.000.00%
FinancialsHighly SpeculativeMicro Cap
Annual cashflow statement for Luckwel Pharmaceuticals, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2017 March 31st | 2018 March 31st | 2019 March 31st | 2020 March 31st | 2021 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | — | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.511 | -0.537 | -0.623 | -0.536 | -0.436 |
| Amortisation | |||||
| Non-Cash Items | 0.006 | 0.004 | 0 | — | — |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.044 | 0.017 | 0 | 0.139 | 0.238 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -0.461 | -0.516 | -0.622 | -0.398 | -0.198 |
| Other Investing Cash Flow Items | 0 | 0 | 0 | 0 | 0 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.404 | 0.505 | 0.629 | 0.372 | 0.2 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.057 | -0.011 | 0.007 | -0.026 | 0.002 |